Pliva D.D.
Records under this name other than patents Pliva D.D. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,569,549 | Isostructural Pseudopolymorphs of 9-Deoxo-9A-AZA-9A-METHYL-9A-HOMOERYTHROMYCIN A Formerly held Term ended Term ended Mar 17, 2023 · High confidence | Term ended | Term ended Mar 17, 2023 | High confidence |
| US 6,110,965 | Ketolides from the class of 15-membered lactams Formerly held Term ended Term ended Jul 31, 2018 · From the USPTO record | Term ended | Term ended Jul 31, 2018 | From the USPTO record |
| US 6,855,707 | Method for the treatment of lipid and glucose metabolism disorders Formerly held Term ended Term ended Apr 28, 2017 · From the USPTO record | Term ended | Term ended Apr 28, 2017 | From the USPTO record |
| US 7,446,097 | Conjugates of immune cell specific macrolide compounds with anti-inflammatory compounds for improved cellular targeting of anti-inflammatory therapy Formerly held Lapsed on the fee record Ended Nov 4, 2016 · From the USPTO record | Lapsed on the fee record | Ended Nov 4, 2016 | From the USPTO record |
| US 6,071,914 | Method for inhibiting neoplastic disease in mammals Formerly held Term ended Term ended May 31, 2016 · From the USPTO record | Term ended | Term ended May 31, 2016 | From the USPTO record |
| US 6,504,035 | 3-deoxy-desmycosin derivatives and process for their preparation Formerly held Lapsed on the fee record Ended Jan 7, 2015 · From the USPTO record | Lapsed on the fee record | Ended Jan 7, 2015 | From the USPTO record |
| US 7,157,433 | Compounds, compositions as carriers for steroid/nonsteroid anti-inflammatory; antienoplastic and antiviral active molecules Formerly held Lapsed on the fee record Ended Jan 2, 2015 · From the USPTO record | Lapsed on the fee record | Ended Jan 2, 2015 | From the USPTO record |
| US 6,900,183 | Macrolide Antibiotics Formerly held Lapsed on the fee record Ended May 31, 2013 · High confidence | Lapsed on the fee record | Ended May 31, 2013 | High confidence |
| US 6,897,211 | Thienodibenzoazulene compounds as tumor necrosis factor inhibitors Formerly held Lapsed on the fee record Ended May 24, 2013 · From the USPTO record | Lapsed on the fee record | Ended May 24, 2013 | From the USPTO record |
| US 6,211,348 | Hydroxy derivatives of tylosin and process for their preparation Formerly held Lapsed on the fee record Ended Apr 3, 2013 · From the USPTO record | Lapsed on the fee record | Ended Apr 3, 2013 | From the USPTO record |